Home › NDC Lookup › RxCUI directory › RxCUI 2539949

Ferric maltol 30 MG Oral Capsule [Accrufer] — RxCUI 2539949

RxNorm drug concept · Semantic branded drug
RxCUI 2539949 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2539949
Official nameFerric maltol 30 MG Oral Capsule [Accrufer]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAccrufer 30 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)54,255 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Ferric maltol 30 MG Oral Capsule [Accrufer] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ferric maltol 30 MG Oral Capsule [Accrufer] RxCUI 2539949

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ferric maltol 2539932
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Accrufer 2539944
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ferric maltol Oral Capsule 2539942
    • Ferric maltol Oral Product 2539940
    • Ferric maltol Pill 2539941
    • Ferric maltol Oral Capsule [Accrufer] 2539946
    • Accrufer Oral Product 2539947
    • Accrufer Pill 2539948
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ferric maltol 30 MG Oral Capsule SCD · 2539943
  • Ferric maltol 30 MG SCDC · 2539939
  • Ferric maltol Oral Capsule SCDF · 2539942
  • Ferric maltol Oral Product SCDG · 2539940
  • Ferric maltol Pill SCDG · 2539941

Brand-Name Concepts

  • Ferric maltol 30 MG [Accrufer] SBDC · 2539945
  • Ferric maltol Oral Capsule [Accrufer] SBDF · 2539946
  • Accrufer Oral Product SBDG · 2539947
  • Accrufer Pill SBDG · 2539948
  • Accrufer BN · 2539944

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2539949 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73059-0001-10 1 BOTTLE, PLASTIC in 1 CARTON (73059-001-10) / 10 CAPSULE i... ACCRUFER Shield TX (UK) Ltd 2022-04-01
73059-0001-60 1 BOTTLE, PLASTIC in 1 CARTON (73059-001-60) / 60 CAPSULE i... ACCRUFER Shield TX (UK) Ltd 2021-07-01
Observed labelers: Shield TX (UK) Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$10.0850
Range $10.0850–$10.0850 · middle 50% $10.0850–$10.0850 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.